Cammarota Antonella

14PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 22, 2026
Circulating tumour DNA in oligometastatic oesophago-gastric cancers: applications, challenges, and future directions.

|Apr 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials.

Rafael Grochot, Kroopa Joshi, Antonella Cammarota

|Feb 20, 2025
Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit.

Antonella Cammarota, Kroopa Joshi, Farah Aghayeva

|Jan 25, 2025
The Immune-Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies.

Antonella Cammarota, Rita Balsano, Tiziana Pressiani

|Jan 16, 2023
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?

Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi

|Dec 11, 2022
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio

Pageof 3

Frequent Collaborators

11 joint publications

Lorenza Rimassa

8 joint publications

Nicola Personeni

7 joint publications

Antonio D'Alessio

5 joint publications

Tiziana Pressiani